# Zhonghe Gene

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/zhonghe-gene

- Industry: Biotechnology
- Headquarters: Tianjin, China
- Website: www.zhonghegene.com/
- Latest round: Angel (Jan 29, 2023)
- Investors on record: 2

## About

Based in Tianjin, China and founded in 2022, Tianjin Zhonghe Gene Technology Co., Ltd., trading as Zhonghe Gene, is a biotechnology company specializing in the development and commercialization of green synthesis equipment based on bio-based DNA synthesis technology. The company possesses over 30 core intellectual property rights and currently has a R&D base in Tianjin and a production base in Changzhou. The company founder and Chief Scientist Officer (CSO), Huifeng Jiang, is a researcher at the Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences. In June 2026, Zhonghe Gene closed Strategic Investment funding from TEDA Venture Capital.

The company develops and manufactures gene synthesis equipment such as the TIESyno®-96 DNA biosynthesizer, gene splicer, and DNA biosynthesis-related reagents and consumables. It also offers bio-based gene synthesis services. The company's products and services are applied in DNA research, synthetic biology, biomedicine, basic research, and DNA storage. 

The company generates revenue from providing gene synthesis equipment and services.

## Funding rounds

- Angel, Jan 29, 2023 — Haihe River Industry Fund, Tianjin Haihe Innovation Investment Management

## Investors

- Haihe River Industry Fund (https://capitalatlas.ai/funds/haihe-river-industry-fund) — Angel
- Tianjin Haihe Innovation Investment Management — Angel